CAMP4 Therapeutics Corp. (CAMP)
4.26
-0.07
(-1.62%)
USD |
NASDAQ |
Nov 11, 12:20
CAMP4 Therapeutics Total Liabilities (Quarterly) : 26.92M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 26.92M |
| June 30, 2026 | 94.12M |
| March 31, 2026 | 74.56M |
| December 31, 2025 | 70.10M |
| September 30, 2025 | 27.73M |
| June 30, 2025 | 11.29M |
| Date | Value |
|---|---|
| March 31, 2025 | 11.20M |
| December 31, 2024 | 15.16M |
| September 30, 2024 | 18.19M |
| June 30, 2024 | 14.91M |
| March 31, 2024 | |
| December 31, 2023 | 16.53M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 406.66M |
| Alnylam Pharmaceuticals, Inc. | 4.391B |
| Anika Therapeutics, Inc. | 52.02M |
| Savara, Inc. | 48.08M |
| Vericel Corp. | 132.94M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 134.01M |
| Shareholders Equity (Quarterly) | 107.09M |
| Debt to Equity Ratio | 0.0602 |
| Current Ratio | 6.420 |
| Net Debt Paydown Yield | 0.06% |